
Search
Filter Results
Displaying 601–610 of 705 for “retinitis clinical trial”
-
XLRP-Patient Focused Drug Development
The goal of the June 7th meeting will be to educate FDA staff and other key stakeholders such as biotech and pharmaceutical companies about what it is like to live with XLRP, with perspectives from both affected individuals as well as caregivers and family members of affected individuals.
-
Mar 3, 2022
Clearside Biomedical Appoints Benjamin R. Yerxa, Ph.D. to its Board of Directors
Industry Veteran Brings Broad Ophthalmology Research & Development Expertise.
-
Feb 1, 2022
Genentech-Roche Receives FDA Approval for Vabysmo for Treatment of Wet AMD and DME
This new treatment can reduce the frequency of injections into the eye
-
Jan 27, 2022
Commitment to expand translational research acceleration program and fund career development award.
-
Dec 27, 2021
In Memoriam: Dr. Alan Laties – Early Leader in Retinal Research
Alan M. Laties, MD, passed away on Sunday, December 26 at the age of 90.
-
Sep 28, 2021
RD Fund Launches Opus Genetics to Advance Gene Therapies for Inherited Retinal Diseases
First two programs are for Leber congenital amaurosis: LCA5-lebercillin and LCA13-RDH12
-
Sep 13, 2021
Telling His Story of Resilience
Chad has been working in the corporate world for the last 20 years. But after becoming the first blind executive to graduate from the Harvard Business School leadership program, he realized his purpose in life is to help others by sharing the lessons he learned while losing his eyesight. He can now add published author to his repertoire with his new book, Blind Ambition.
-
Jun 4, 2021
Foundation Fighting Blindness to Host National Virtual VisionWalk
The Spring Virtual VisionWalk on June 12th will raise awareness and fund research finding treatments and cures for blinding retinal diseases.
-
The bill would provide loans to therapy developers ready to launch clinical trials for a broad range of conditions including retinal and eye diseases.
-
Apr 26, 2021
Ambitious Swimmer Spreading Optimism
26-year-old Becca is a two-time Paralympic swimmer for Team USA, diagnosed with Usher syndrome type 1 (USH1) at only four years old. But she has never let her diagnosis with Usher syndrome stop her from doing exactly what she puts her mind to.